{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T15:22:10Z","timestamp":1774624930392,"version":"3.50.1"},"reference-count":26,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,7,19]],"date-time":"2021-07-19T00:00:00Z","timestamp":1626652800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell Dev. Biol."],"abstract":"<jats:p>Trypanosomatid parasites, including <jats:italic>Trypanosoma<\/jats:italic> and <jats:italic>Leishmania<\/jats:italic>, are infectious zoonotic agents for a number of severe diseases such as African sleeping sickness and American trypanosomiasis (Chagas disease) that affect millions of people, mostly in the emergent world. The glycosome is a specialized member of the peroxisome family of organelles found in trypanosomatids. These organelles compartmentalize essential enzymes of the glycolytic pathway, making them a prime target for drugs that can kill these organisms by interfering with either their biochemical functions or their formation. Glycosome biogenesis, like peroxisome biogenesis, is controlled by a group of proteins called peroxins (Pex). Pex3 is an early acting peroxin that docks Pex19, the receptor for peroxisomal membrane proteins, to initiate biogenesis of peroxisomes from the endoplasmic reticulum. Identification of Pex3 as the essential master regulator of glycosome biogenesis has implications in developing small molecule inhibitors that can impede Pex3\u2013Pex19 interaction. Low amino acid sequence conservation between trypanosomatid Pex3 and human Pex3 (HsPex3) would aid in the identification of small molecule inhibitors that selectively interfere with the trypanosomatid Pex3\u2013Pex19 interaction. We tested a library of pharmacologically active compounds in a modified yeast two-hybrid assay and identified a compound that preferentially inhibited the interaction of <jats:italic>Trypanosoma brucei<\/jats:italic> Pex3 and Pex19 versus HsPex3 and Pex19. Addition of this compound to either the insect or bloodstream form of <jats:italic>T. brucei<\/jats:italic> disrupted glycosome biogenesis, leading to mislocalization of glycosomal enzymes to the cytosol and lethality for the parasite. Our results show that preferential disruption of trypanosomal Pex3 function by small molecule inhibitors could help in the accelerated development of drugs for the treatment of trypanosomiases.<\/jats:p>","DOI":"10.3389\/fcell.2021.703603","type":"journal-article","created":{"date-parts":[[2021,7,19]],"date-time":"2021-07-19T09:20:37Z","timestamp":1626686437000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":14,"title":["A Small Molecule Inhibitor of Pex3\u2013Pex19 Interaction Disrupts Glycosome Biogenesis and Causes Lethality in Trypanosoma brucei"],"prefix":"10.3389","volume":"9","author":[{"given":"Hiren","family":"Banerjee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"LaPointe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary","family":"Eitzen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard A.","family":"Rachubinski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,7,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.26508\/lsa.201900421","article-title":"The early-acting glycosome biogenic protein Pex3 is essential for trypanosome viability.","volume":"2","author":"Banerjee","year":"2019","journal-title":"Life Sci. Alliance"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0001320","article-title":"Functional expression of parasite drug targets and their human orthologs in yeast.","volume":"5","author":"Bilsland","year":"2011","journal-title":"PLoS Negl. Trop. Dis."},{"key":"B3","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1042\/BC20060023","article-title":"Identification of TRIO-GEFD1 chemical inhibitors using the yeast exchange assay.","volume":"98","author":"Blangy","year":"2006","journal-title":"Biol. Cell"},{"key":"B4","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1006\/jmbi.2000.3910","article-title":"Structure of Type 2 peroxisomal targeting signals in two trypanosomatid aldolases.","volume":"300","author":"Chudzik","year":"2000","journal-title":"J. Mol. Biol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1042\/BST20190517","article-title":"Glycosome heterogeneity in kinetoplastids.","volume":"49","author":"Crowe","year":"2021","journal-title":"Biochem. Soc. Trans."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1126\/science.aal1807","article-title":"Inhibitors of PEX14 disrupt protein import into glycosomes and kill Trypanosoma parasites.","volume":"355","author":"Dawidowski","year":"2017","journal-title":"Science"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3390\/tropicalmed5010014","article-title":"The drugs of sleeping sickness: Their mechanisms of action and resistance, and a brief history.","volume":"5","author":"De Koning","year":"2020","journal-title":"Trop. Med. Infect. Dis."},{"key":"B8","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1038\/s41586-018-0327-4","article-title":"Challenges and recent progress in drug discovery for tropical diseases.","volume":"559","author":"de Rycker","year":"2018","journal-title":"Nature"},{"key":"B9","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1083\/jcb.200311131","article-title":"PEX3 functions as a PEX19 docking factor in the import of class1 peroxisomal membrane proteins.","volume":"164","author":"Fang","year":"2004","journal-title":"J. Cell Biol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1091\/mbc.11.6.2085","article-title":"The peroxin Pex3p initiates membrane assembly in peroxisome biogenesis.","volume":"11","author":"Ghaedi","year":"2000","journal-title":"Mol. Biol. Cell"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.1017\/s0031182016001268","article-title":"The animal trypanosomiases and their chemotherapy: a review.","volume":"143","author":"Giordani","year":"2016","journal-title":"Parasitology"},{"key":"B12","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1042\/BJ20150042","article-title":"The multidrug transporter Pdr5 on the 25th anniversary of its discovery: an important model for the study of asymmetric ABC transporters.","volume":"467","author":"Golin","year":"2015","journal-title":"Biochem. J."},{"key":"B13","doi-asserted-by":"publisher","first-page":"2651","DOI":"10.1242\/jcs.115.13.2651","article-title":"Compartmentation of enzymes in a microbody, the glycosome, is essential in Trypanosoma brucei.","volume":"115","author":"Guerra-Giraldez","year":"2002","journal-title":"J. Cell Sci."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1016\/j.bbamcr.2015.09.015","article-title":"Biogenesis, maintenance, and dynamics of glycosomes in trypanosomatid parasites.","volume":"1863","author":"Haanstra","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"B15","doi-asserted-by":"publisher","first-page":"17718","DOI":"10.1073\/pnas.0806664105","article-title":"Compartmentation prevents a lethal turbo-explosion of glycolysis in trypanosomes.","volume":"105","author":"Haanstra","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamcr.2019.07.015","article-title":"Evolutionarily divergent PEX3 is essential for glycosome biogenesis and survival of trypanosomatid parasites.","volume":"1866","author":"Kalel","year":"2019","journal-title":"Biochim. Biophys Acta"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3390\/molecules25092064","article-title":"Naphthoquinones as covalent reversible inhibitors of cysteine proteases studies on inhibition mechanism and kinetics.","volume":"25","author":"Klein","year":"2020","journal-title":"Molecules"},{"key":"B18","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1517\/14728222.12.4.505","article-title":"The yeast two-hybrid system and its role in drug discovery.","volume":"12","author":"Lentze","year":"2008","journal-title":"Expert Opin. Ther. Targets"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3390\/tropicalmed2030036","article-title":"Neglected tropical diseases: epidemiology and global burden.","volume":"2","author":"Mitra","year":"2017","journal-title":"Trop. Med. Infect. Dis."},{"key":"B20","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1038\/nrd2144","article-title":"Innovative lead discovery strategies for tropical diseases.","volume":"5","author":"Nwaka","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0002012","article-title":"Naphthoquinone derivatives exert their antitrypanosomal activity via a multi-target mechanism.","volume":"7","author":"Pieretti","year":"2013","journal-title":"PLoS Negl. Trop. Dis."},{"key":"B22","doi-asserted-by":"publisher","first-page":"6136","DOI":"10.1074\/jbc.m706139200","article-title":"Characterization of the interaction between recombinant human peroxin Pex3p and Pex19p: identification of Trp-104 in Pex3p as a critical residue for the interaction.","volume":"283","author":"Sato","year":"2008","journal-title":"J. Biol. Chem."},{"key":"B23","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1038\/nrm3700","article-title":"Peroxisomes take shape.","volume":"14","author":"Smith","year":"2013","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1172\/jci33945","article-title":"Kinetoplastids: related pathogens, different diseases.","volume":"118","author":"Stuart","year":"2008","journal-title":"J. Clin. Invest."},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1186\/s12915-017-0446-7","article-title":"A yeast two-hybrid system for screening and characterization of small molecule inhibitors of protein-protein interactions identifies a novel putative Mdm2-binding site p53.","volume":"15","author":"Wong","year":"2017","journal-title":"BMC Biol."},{"key":"B26","year":"2017","journal-title":"Integrating Neglected Tropical Diseases in Global Health and Development."}],"container-title":["Frontiers in Cell and Developmental Biology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2021.703603\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,19]],"date-time":"2021-07-19T09:20:40Z","timestamp":1626686440000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2021.703603\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,19]]},"references-count":26,"alternative-id":["10.3389\/fcell.2021.703603"],"URL":"https:\/\/doi.org\/10.3389\/fcell.2021.703603","relation":{},"ISSN":["2296-634X"],"issn-type":[{"value":"2296-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,19]]},"article-number":"703603"}}